ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Apr 2026
Jan 2026
Latest Journal Issues
Nuclear Science and Engineering
June 2026
Nuclear Technology
March 2026
Fusion Science and Technology
May 2026
Latest News
DOE selects first companies for nuclear launch pad
The Department of Energy’s Office of Nuclear Energy and the National Reactor Innovation Center have announced their first selections for the Nuclear Energy Launch Pad: three companies developing microreactors and one developing fuel supply.
The four companies—Deployable Energy, General Matter, NuCube Energy, and Radiant Industries—were selected from the initial pool of Reactor Pilot Program and Fuel Line Pilot Program applicants, the two precursor programs to the launch pad.
Otto K. Harling, Jacquelyn C. Yanch, J. Richard Choi, Guido R. Solares, Ronald D. Rogus, Damien J. Moulin, L. Scott Johnson, Ilhan Olmez, Stefan Wirdzek, John A. Bernard, Robert G. Zamenhof, Charles I. Nwanguma, David E. Wazer, Stephen Saris,Hywel Madoc-Jones,Clement B. Sledge, Sonya Shortkroff
Nuclear Science and Engineering | Volume 110 | Number 4 | April 1992 | Pages 330-348
Technical Paper | doi.org/10.13182/NSE92-A23907
Articles are hosted by Taylor and Francis Online.
Current research in boron neutron capture therapy (BNCT) and radiation synovectomy at the Massachusetts Institute of Technology Research Reactor is reviewed. In the last few years, major emphasis has been placed on the development of BNCT primarily for treatment of brain tumors. This has required a concerted effort in epithermal beam design and construction as well as the development of analytical capabilities for 10B analysis and patient treatment planning. Prompt gamma analysis and high-resolution track-etch autoradiography have been developed to meet the needs, respectively, for accurate bulk analysis and for quantitative imaging of 10B in tissue at subcellular resolutions. Monte Carlo-based treatment planning codes have been developed to ensure optimized and individualized patient treatments. In addition, the development of radiation synovectomy as an alternative therapy to surgical intervention in joints that are affected by rheumatoid arthritis is described.